← feed

Is NCT04889391 results overdue?

Yes — results are overdue. Primary completion was 2017-10-15; the FDAAA-801 reporting deadline (2018-10-15) passed 2806 days ago and no results are posted on ClinicalTrials.gov.

Study of Radiolabeled Danicopan in Healthy Male Participants

NCT IDNCT04889391 ↗
SponsorAlexion Pharmaceuticals, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-10-15 (ACTUAL)
Reporting deadline2018-10-15 (completion + 365d)
Days overdue2806
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 529c0d2e7bf35d21… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04889391. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →